Inherited lung cancer syndromes targeting never smokers

Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, pred...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Translational lung cancer research 2018-08, Vol.7 (4), p.498-504
Hauptverfasser: Yamamoto, Hiromasa, Yatabe, Yasushi, Toyooka, Shinichi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 504
container_issue 4
container_start_page 498
container_title Translational lung cancer research
container_volume 7
creator Yamamoto, Hiromasa
Yatabe, Yasushi
Toyooka, Shinichi
description Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline T790M mutations had secondary somatic mutations. Never smokers with germline T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline T790M mutations favored female gender. Therefore, germline T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 ( ). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline G660D mutations. They had no somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our analyses, we administered inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as and may have different features from those with sporadic mutations.
doi_str_mv 10.21037/tlcr.2018.06.01
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>30225213</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</originalsourceid><addsrcrecordid>eNpVkEtLAzEUhYMottTuXcn8gRnvTTJJZiNI8VEQ3Og6ZJJMOzqPkkwL_fd2rBZd3QOH71z4CLlGyCgCk7dDY0NGAVUGIgM8I1NKqUg5l_J8zKhSIXOckHmMHwCAvOB5XlySCQNKc4psSuSyW_tQD94lzbZbJdZ01ock7jsX-tbHZDBh5Yf6UHV-NzZt_-lDvCIXlWmin__cGXl_fHhbPKcvr0_Lxf1LarmgQ2pKlTthvKtcDkoKJ7yQ1imQXFYWjSrRUlEWonBKsIKjc8hz6RmrnABJ2YzcHXc327L1zvpuCKbRm1C3Jux1b2r9v-nqtV71Oy2QISo4DMBxwIY-xuCrE4ugvz3q0aMePWoQGvCA3Pz9eQJ-rbEvKltwcQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Inherited lung cancer syndromes targeting never smokers</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</creator><creatorcontrib>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</creatorcontrib><description>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline T790M mutations had secondary somatic mutations. Never smokers with germline T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline T790M mutations favored female gender. Therefore, germline T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 ( ). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline G660D mutations. They had no somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our analyses, we administered inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as and may have different features from those with sporadic mutations.</description><identifier>ISSN: 2218-6751</identifier><identifier>EISSN: 2226-4477</identifier><identifier>DOI: 10.21037/tlcr.2018.06.01</identifier><identifier>PMID: 30225213</identifier><language>eng</language><publisher>China: AME Publishing Company</publisher><subject>Review</subject><ispartof>Translational lung cancer research, 2018-08, Vol.7 (4), p.498-504</ispartof><rights>2018 Translational Lung Cancer Research. All rights reserved. 2018 Translational Lung Cancer Research.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131180/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131180/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30225213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Yatabe, Yasushi</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><title>Inherited lung cancer syndromes targeting never smokers</title><title>Translational lung cancer research</title><addtitle>Transl Lung Cancer Res</addtitle><description>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline T790M mutations had secondary somatic mutations. Never smokers with germline T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline T790M mutations favored female gender. Therefore, germline T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 ( ). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline G660D mutations. They had no somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our analyses, we administered inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as and may have different features from those with sporadic mutations.</description><subject>Review</subject><issn>2218-6751</issn><issn>2226-4477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkEtLAzEUhYMottTuXcn8gRnvTTJJZiNI8VEQ3Og6ZJJMOzqPkkwL_fd2rBZd3QOH71z4CLlGyCgCk7dDY0NGAVUGIgM8I1NKqUg5l_J8zKhSIXOckHmMHwCAvOB5XlySCQNKc4psSuSyW_tQD94lzbZbJdZ01ock7jsX-tbHZDBh5Yf6UHV-NzZt_-lDvCIXlWmin__cGXl_fHhbPKcvr0_Lxf1LarmgQ2pKlTthvKtcDkoKJ7yQ1imQXFYWjSrRUlEWonBKsIKjc8hz6RmrnABJ2YzcHXc327L1zvpuCKbRm1C3Jux1b2r9v-nqtV71Oy2QISo4DMBxwIY-xuCrE4ugvz3q0aMePWoQGvCA3Pz9eQJ-rbEvKltwcQ</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Yamamoto, Hiromasa</creator><creator>Yatabe, Yasushi</creator><creator>Toyooka, Shinichi</creator><general>AME Publishing Company</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180801</creationdate><title>Inherited lung cancer syndromes targeting never smokers</title><author>Yamamoto, Hiromasa ; Yatabe, Yasushi ; Toyooka, Shinichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-ab85d6aedfd50876d6e67cd80747fc1a8b1c26b969d863941dd1457e33fd60723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Hiromasa</creatorcontrib><creatorcontrib>Yatabe, Yasushi</creatorcontrib><creatorcontrib>Toyooka, Shinichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational lung cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Hiromasa</au><au>Yatabe, Yasushi</au><au>Toyooka, Shinichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inherited lung cancer syndromes targeting never smokers</atitle><jtitle>Translational lung cancer research</jtitle><addtitle>Transl Lung Cancer Res</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>7</volume><issue>4</issue><spage>498</spage><epage>504</epage><pages>498-504</pages><issn>2218-6751</issn><eissn>2226-4477</eissn><abstract>Lung cancer is the leading cause of cancer death worldwide. Most of lung cancers develop sporadically and thus inherited lung cancers are rare. Several reports show that germline mutations in the kinase domain of epidermal growth factor receptor ( ) such as R776G, R776H, T790M, V843I and P848L, predispose to develop lung cancer. Most lung cancer cases with germline T790M mutations had secondary somatic mutations. Never smokers with germline T790M mutations develop lung cancer more frequently than ever smokers. In addition, germline T790M mutations favored female gender. Therefore, germline T790M mutations result in a unique inherited lung cancer syndrome targeting never smokers. The authors previously reported a Japanese familial lung cancer pedigree with germline mutations in the transmembrane domain of human epidermal growth factor receptor 2 ( ). The female proband and her mother in this pedigree, who were light or never smokers, developed multiple lung adenocarcinomas, and had germline G660D mutations. They had no somatic mutations or other genes known to cause lung cancers. Although we know only one pedigree with germline mutations, these mutations may also cause inherited lung cancers targeting female never smokers. Based on our analyses, we administered inhibitor afatinib to the proband and achieved partial response. These lung cancers arising from germline mutations of receptor tyrosine kinases such as and may have different features from those with sporadic mutations.</abstract><cop>China</cop><pub>AME Publishing Company</pub><pmid>30225213</pmid><doi>10.21037/tlcr.2018.06.01</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2218-6751
ispartof Translational lung cancer research, 2018-08, Vol.7 (4), p.498-504
issn 2218-6751
2226-4477
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6131180
source EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Review
title Inherited lung cancer syndromes targeting never smokers
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A32%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inherited%20lung%20cancer%20syndromes%20targeting%20never%20smokers&rft.jtitle=Translational%20lung%20cancer%20research&rft.au=Yamamoto,%20Hiromasa&rft.date=2018-08-01&rft.volume=7&rft.issue=4&rft.spage=498&rft.epage=504&rft.pages=498-504&rft.issn=2218-6751&rft.eissn=2226-4477&rft_id=info:doi/10.21037/tlcr.2018.06.01&rft_dat=%3Cpubmed_cross%3E30225213%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30225213&rfr_iscdi=true